Charles has participated in a broad spectrum of activities in drug development and clinical usage, focusing on clinical pharmacology. He has been involved in local and global drug development in Phases I to IV, including product launching and medical marketing, for over two decades with Janssen China, Asubio Pharmaceuticals (Daiichi Sankyo subsidiary), Aventis-Sanofi, Hoffmann-La Roche, and Roche Laboratory Inc. In addition, he has experience in screening and transitioning drug pipelines from preclinical to clinical development, launching and promoting new drugs, and working in hospital and retail pharmacies. Charles is a Diplomate of the American Board of Clinical Pharmacology, a Fellow of the College of Clinical Pharmacology, an editorial review board member, and has over 40 publications and presentations.
His therapeutic area experience includes amyotrophic lateral sclerosis, antibacterial, asthma/COPD, cardiovascular, depression, dermatology, diabetes, hematology, HBV, HIV, influenza, irritable bowel syndrome, metabolism, multiple sclerosis, oncology, Parkinson’s disease, schizophrenia, rheumatoid arthritis, stroke, and transplant.